Markets.com Logo

IBIO

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.7389$
  • Previous Close
    0.7787$
  • 52 Week Change
    6.33$
  • Day Range
    -0.04$
  • 52 Week High/Low
    0.5562$ - 6.8908$
  • Dividend Per Share
    --
  • Market cap
    12 591 K$
  • EPS
    -0.49
  • Beta
    0.602
  • Volume
    --

About

IBIO.US is the stock ticker symbol for iBio, Inc., a biotechnology company. iBio focuses on developing and manufacturing plant-based biopharmaceuticals, including vaccines and therapeutic proteins. Their proprietary FastPharming System allows for rapid and scalable production of these biopharmaceuticals. The company is involved in research and development related to various diseases and conditions.

Global Bond Market Volatility: Record Issuance & Yield Spikes Amid Concerns

Emma Rose|--

US Tariffs After Court Ruling: Potential Impacts and Future Scenarios

Ava Grace|--
RGTI stock price prediction: What is the price target for RGTI in 2025?

RGTI stock price prediction: What is the price target for RGTI in 2025?

Ghko B|--
Crypto IPO 2025: Figure (FIGR), Gemini (GEMI) Announce Launch of IPO

Crypto IPO 2025: Figure (FIGR), Gemini (GEMI) Announce Launch of IPO

Ghko B|--
Crypto Related Stocks Analysis: VVPR, DJT Stock, UPXI, BMNR, SBET

Crypto Related Stocks Analysis: VVPR, DJT Stock, UPXI, BMNR, SBET

Frances Wang|--

UK and France: Economic Challenges and Speculation of IMF Intervention

Noah Lee|--

September Stock Market Outlook: Fed Rate Cut Uncertainty Looms

Emma Rose|--

Factors

Clinical Trial Results: Positive data from IBIO's clinical trials typically drive the stock price up, while negative results can cause it to fall.

Regulatory Approvals: Receiving FDA or other regulatory approvals for their products would significantly boost investor confidence and the stock price.

Partnerships & Collaborations: Forming strategic alliances with other pharmaceutical companies or research institutions can positively affect the stock price.

Market Sentiment: Overall market conditions and investor sentiment towards the biotechnology sector influence IBIO's stock price.

Financial Performance: IBIO's revenue, expenses, and cash flow can impact investor perception and stock valuation.

Competition: The presence and success of competitors in the same therapeutic areas can put pressure on IBIO's stock.

News & Announcements: Company-specific news releases about new product developments, partnerships, or financial results affect the stock.

Intellectual Property: The strength and scope of IBIO's patents and intellectual property portfolio contribute to its perceived value.

Manufacturing Capacity: IBIO's ability to produce and scale up manufacturing of its products impacts its potential for commercial success.

Management Team: The experience and reputation of IBIO's management team affect investor confidence.

People Also Watch

Latest news

Trump's Fed Nominee Faces Confirmation Hearing: Will He Reshape the Central Bank?

Sophia Claire|--

OPEC+ Considers Output Hike Amid Market Share Battle

Ava Grace|--

UK Budget 2024: Reeves' Fiscal Challenge Amid Global Economic Concerns

Noah Lee|--

Latest Education Articles

 BTC-USD Climbs Back Above $111K: How to Trade Bitcoin CFDs?

BTC-USD Climbs Back Above $111K: How to Trade Bitcoin CFDs?

Frances Wang|--
Types of Commodities CFD Trading: Gold CFDs, Silver CFDs, Oil CFDs

Types of Commodities CFD Trading: Gold CFDs, Silver CFDs, Oil CFDs

Frances Wang|--
CFD Trading in Forex Market: USD/JPY, EUR/USD, AUD/USD

CFD Trading in Forex Market: USD/JPY, EUR/USD, AUD/USD

Frances Wang|--